AdvanSix Inc. (NYSE:ASIX – Get Free Report) shares dropped 0.8% during trading on Tuesday . The company traded as low as $31.08 and last traded at $31.38. Approximately 7,506 shares were traded during trading, a decline of 95% from the average daily volume of 140,161 shares. The stock had previously closed at $31.64.
Analyst Ratings Changes
ASIX has been the topic of a number of research analyst reports. StockNews.com upgraded AdvanSix from a “hold” rating to a “buy” rating in a research report on Wednesday, December 4th. Piper Sandler boosted their price target on AdvanSix from $35.00 to $39.00 and gave the company an “overweight” rating in a research report on Friday, November 8th.
Check Out Our Latest Stock Report on AdvanSix
AdvanSix Price Performance
AdvanSix Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 2.02%. The ex-dividend date was Tuesday, November 12th. AdvanSix’s dividend payout ratio (DPR) is presently 45.39%.
Insiders Place Their Bets
In other AdvanSix news, CEO Erin N. Kane sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $30.28, for a total transaction of $151,400.00. Following the transaction, the chief executive officer now owns 522,795 shares in the company, valued at approximately $15,830,232.60. The trade was a 0.95 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Christopher Gramm sold 2,435 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $32.00, for a total value of $77,920.00. Following the sale, the insider now directly owns 43,463 shares in the company, valued at $1,390,816. This trade represents a 5.31 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,369 shares of company stock worth $474,058. Company insiders own 5.60% of the company’s stock.
Institutional Investors Weigh In On AdvanSix
Several institutional investors have recently modified their holdings of ASIX. SummerHaven Investment Management LLC lifted its stake in AdvanSix by 3.4% in the 2nd quarter. SummerHaven Investment Management LLC now owns 20,404 shares of the company’s stock valued at $468,000 after buying an additional 672 shares in the last quarter. Meritage Portfolio Management raised its holdings in AdvanSix by 9.1% in the 3rd quarter. Meritage Portfolio Management now owns 10,429 shares of the company’s stock valued at $317,000 after acquiring an additional 871 shares during the last quarter. Copeland Capital Management LLC acquired a new position in AdvanSix in the 3rd quarter valued at $41,000. Public Employees Retirement System of Ohio raised its holdings in AdvanSix by 29.9% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 6,067 shares of the company’s stock valued at $184,000 after acquiring an additional 1,396 shares during the last quarter. Finally, Point72 DIFC Ltd acquired a new position in AdvanSix in the 2nd quarter valued at $34,000. Hedge funds and other institutional investors own 86.39% of the company’s stock.
AdvanSix Company Profile
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Read More
- Five stocks we like better than AdvanSix
- What Investors Need to Know About Upcoming IPOs
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- P/E Ratio Calculation: How to Assess Stocks
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Tesla’s Closes in on $400: From Laggard to Leader in 2024
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.